NEULAND LABORATORIES
|
The Current P/S Ratio of NEULAND LABORATORIES is 10.76.
| Share Price | ₹19,942.8 | Oct 15,2026 |
| Market Cap | ₹25,526.8 Cr | |
| Sales-TTM | ₹2,371.8 Cr | TTM-Consolidated Results |
| Price/Sales | 10.76x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of NEULAND LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹25,526.8 Cr] as on Oct 15,2026
(/) Sales [ ₹2,371.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 10.76x ]
Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '10.76 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NEULAND LABORATORIES !
The chart below summarizes the trend in P/S Ratio of NEULAND LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of NEULAND LABORATORIES
PS Ratio Performance Analysis for NEULAND LABORATORIES
- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 5.32x.
- NEULAND LABORATORIES 's operated at median p/e ratio of 5.17x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2025 at 10.49x.
- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 1.38x.
How does NEULAND LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| NEULAND LABORATORIES | 2,371.8 | 10.76 | 25,526.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.05 | 422,427.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 21.37 | 239,982.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.14 | 175,196.0 |
| CIPLA LTD | 28,324.4 | 3.80 | 107,746.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.07 | 101,894.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.60 | 97,263.9 |
| LUPIN LTD | 29,966.6 | 2.99 | 89,592.2 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.98 | 113,790.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.76 | 96,375.8 |
| LAURUS LABS LTD | 7,269.6 | 15.01 | 109,143.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NEULAND LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.76x |
| Max industry PS | 21.37x |
| Median industry PS | 6.60x |
| Average industry PS | 8.05x |
You may also like the below Video Courses